H.C. Wainwright & Co. is acting as manager.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PPBT:
- Purple Biotech Reports Q2 2025 Financial Results and Clinical Progress
- Purple Biotech reports Q2 EPS 40c vs $1.80 last year
- Purple Biotech Highlights Clinical Milestones and Pipeline Progress in H1 2025
- Purple Biotech issues letter to shareholders from CEO
- Purple Biotech Unveils July 2025 Update on Cancer Drug Development